Page 45 - சூரியன் மருந்து தொழில்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Anti-Infective Drugs Market Present Scenario, Key Vendors, Industry Share, and Growth Forecas

Global Anti-Infective Drugs Market Present Scenario, Key Vendors, Industry Share, and Growth Forecas
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomSouth koreaRepublic ofSouth africaSaudi arabiaZydus pharmaAurobindo pharmaAmneal pharmaceuticalsRoche ltdAlembic pharmaceuticalsCipla incLaurus labs ltdSun pharmaceutical industries ltdGilead sciences inc

Active Pharmaceutical Ingredient Market to Hit USD 261 28 Billion and Exhibit 6 1% CAGR by 2026; Rising Demand for Biosimilar & Biologics to Drive Growth: Fortune Business Insights™

Top Players Covered in the Active Pharmaceutical Ingredient Market Research Report Are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Abbott, Biocon, Cipla Inc., Amgen Inc. and other key market players.Pune, India, March 10, 2021 (GLOBE NEWSWIRE) The global Active Pharmaceutical Ingredient Market size is set to gain impetus from the rising implementation of strict norms and regulations in several countries regarding the production of high-quality API. It is further aiding in upsurging the overhead costs of in-house API manufacturing. Therefore, numerous pharmaceutical companies are focusing on outsourcing the manufacturing. This information is provided by Fortune Business Insights™ in a recent report, the report further mentions that the Active Pharmaceutical Ingredient Market size stood at USD 164.20 billion in 2018 and is projected to reach USD 261.28 billion by 2026, e

Active pharmaceutical ingredientsBusiness insightsTeva pharmaceutical industries ltdDr reddys laboratories ltdAurobindo pharmaAmgen incMarket analysisSun pharmaceutical industries ltdGlobal marketAbbvie incPharmaceutical industriesMarket researchChronic diseasesAsia pacificNorth americaசெயலில் மருந்து பொருட்கள்

Over the Counter (OTC) Drugs Market Set to Register Healthy CAGR and Competitive Outlook to 2026 By

Search jobs 10-Mar-2021 Over the Counter (OTC) Drugs Market Set to Register Healthy CAGR and Competitive Outlook to 2026 By Top Prominent Key Players Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited The newly added report by Data Bridge Market Research entitled Global Over the Counter (OTC) Drugs Market Size, Share, Growth, Industry Trends and Forecast to 2028 gives productive ideas, updated information with the latest market intelligence and which supports with the strategic investment decisions. The report provides a thorough analysis of the current trends, opportunities, drivers, and restraints in the global Over the Counter (OTC) Drugs. The report concentrates on top players and their overview of the market, covering various aspects such as product definition, market segmentation, and the prevailing vendor landscape, manufacturing, and pricing and cost structures. The repor

United statesHong kongUnited kingdomNew zealandSouth koreaSouth africaBy productsKwazulu natalUnited arab emiratesSaudi arabiaAsia pacificSun pharmaceutical industries ltdTakeda pharmaceutical companyTeva pharmaceutical industries ltdPfizer incConsumer healthcare products association

Global Sinusitis Drugs Market Value to Increase by $ 466 44 Million During 2021-2025 | 39% Growth to Originate from North America

Share this article Share this article USD 466.44 million during 2020-2024. Technavio segments the Sinusitis drugs market by product (steroid nasal sprays, antibiotics, decongestants, and other drugs) and geography (North America, Europe, Asia, and ROW). The report identifies the rising prevalence of sinusitis as one of the major factors propelling the market growth. Ask for a Free Sample Report: Sinusitis Drugs Market by Product and Geography - Forecast and Analysis 2021-2025 The growing incidence of risk factors such as allergies, pollutants (airborne chemicals or irritants), and fungal infections has increased the prevalence of sinus infections globally. For Instance, on average, nine out of ten adults and 5-7 out of 10 children in the US have sinus infections. Besides, other factors such as the rising use of pacifiers, feeding while laying down, and exposure to second-hand smoke have increased the prevalence of the condition among most of the population globally. All thes

United statesUnited kingdomJesse maidaBayer agGlaxosmithkline plcTechnavio researchHikma pharmaceuticals plcMerck coSun pharmaceutical industries ltdNeopharma corpPfizer incAbbvie incDrugs marketVendors coveredSinusitis drugsDrugs market report

Mosquito-borne Disease Mitigation Centers Around Antiviral Therapy: Study

Published: Mar 08, 2021 Investments towards research of live attenuated vaccines for mosquito-borne disease treatments in major population centers is generating better prospects for sales. Fact.MR Rockville, MD: An ongoing report on the mosquito-borne disease treatments market by market research firm Fact.MR has projected positive growth prospects for 2021. The covid-19 pandemic has moderately impacted the industry owing to the redirection of healthcare facilities towards the new threat of the coronavirus. However, continued concerns over vector-borne disease is expected to sustain steady growth in the market in the coming years. According to the World Mosquito Program, close to 700 million people globally contract mosquito borne ailments annually, which results in approximately a million deaths. In recent years, dengue cases have risen strongly and 40 percent of the global population is considered to be at risk, with around 25,000 patients succumbing to the disease annually.

United arab emiratesUnited statesRockville pikeSudip sahaAsia pacificUs sales officeWorld mosquito programBrazilian industrial property officeMerck coSun pharmaceutical industries ltdLupin incConserv bioscience ltdPfizer incWest nileDiseases treatment marketMosquito borne diseases treatment